行情

CVM

CVM

CEL SCI
AMEX

实时行情|Nasdaq Last Sale

22.17
+0.66
+3.07%
盘后: 22.25 +0.08 +0.36% 17:44 06/18 EDT
开盘
21.05
昨收
21.51
最高
22.62
最低
21.01
成交量
136.45万
成交额
--
52周最高
40.91
52周最低
10.76
市值
9.43亿
市盈率(TTM)
-24.4109
分时
5日
1月
3月
1年
5年
Cel-Sci 完成 3170 万美元的买入交易
MT Newswires · 06/11 12:39
28 只股票在周三的盘前交易时段内波动
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) rose 72.4% to $3.81 in pre-market trading following Zacks article 'AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An Infected Patient.'
Benzinga · 06/09 11:00
CEL-SCI 股票在通过二次股票发行筹集 3710 万美元后下跌
Benzinga · 06/09 10:30
由于需求,Cel-Sci 将购买交易增至 3170 万美元
MT Newswires · 06/09 04:11
Brief-CEL-SCI 将先前宣布的买入交易增加至 3170 万美元
reuters.com · 06/09 01:06
CEL-SCI 宣布以 22.62 美元/股的价格购买 100 万股股票
CEL-SCI Corporation (NYSE:CVM, ", >, )))), a Phase 3 cancer immunotherapy company,today announced that it has entered into an underwriting agreement with Kingswood Capital Markets, division of Benchmark
Benzinga · 06/08 20:37
Cel-Sci 称承销商同意购买至少 100 万股
MT Newswires · 06/08 17:11
Brief-CEL-SCI报告第二季度每股亏损0.28美元
reuters.com · 05/18 13:11
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解CVM最新的财务预测,通过CVM每股收益,每股净资产,每股现金流等数据分析CEL SCI近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测CVM价格均价为19.00,最高价位19.00,最低价为19.00。
EPS
机构持股
总机构数: 69
机构持股: 585.04万
持股比例: 13.76%
总股本: 4,252.91万
类型机构数股数
增持
19
265.68万
建仓
30
49.35万
减持
4
17.75万
平仓
3
24.38万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
-1.19%
制药与医学研究
-0.98%
高管信息
Chief Executive Officer/Director/Treasurer
Geert Kersten
Senior Vice President/Secretary
Patricia Prichep
Senior Vice President
John Cipriano
Senior Vice President
Daniel Zimmerman
Chief Scientific Officer
Eyal Talor
Independent Director
Bruno Baillavoine
Independent Director
Robert Watson
Independent Director
Peter Young
暂无数据
CVM 简况
CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for treatment of certain head and neck cancers, and anal warts or cervical dysplasia in human immunodeficiency virus and human papillomavirus co-infected patients and Ligand Epitope Antigen Presentation System (L.E.A.P.S.) technology, with over two investigational therapies, LEAPS-H1N1-DC, a product candidate under development for treatment of pandemic influenza in hospitalized patients, and CEL-2000 and CEL-4000, vaccine product candidates under development for treatment of rheumatoid arthritis.

微牛提供CEL-SCI Corporation(AMEX-CVM)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的CVM股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CVM股票基本功能。